GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

PAHC · Dec 31, 2023

PHIBRO ANIMAL HEALTH CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001558370-24-000859General Corporate
Debt relative to revenueRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.debt_to_revenue

129.59% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

4.38% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

12.63% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

114.70% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

31.45% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

6.28% · CORE · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

0.03% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building
Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20255/8 normalizedLevel 3Sep 30, 20256/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
142.15%
Current
129.59%
Delta
-12.56%
Capex Intensity Increased
Previous
3.23%
Current
4.38%
Delta
1.15%
Cash Generation Increased
Previous
7.00%
Current
12.63%
Delta
5.62%
Inventory Pressure Decreased
Previous
120.66%
Current
114.70%
Delta
-5.97%
Margin Increased
Previous
29.27%
Current
31.45%
Delta
2.18%
Profitability Increased
Previous
-0.31%
Current
6.28%
Delta
6.60%
Sbc Intensity Decreased
Previous
0.04%
Current
0.03%
Delta
-0.00%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · PAHC Fundamental State →Has State · PHIBRO ANIMAL HEALTH CORP →Transitioned To · PAHC Fundamental State →Transitioned To · PAHC BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · PAHC CAPEX_INTENSITY_INCREASED →Transitioned To · PAHC CASH_GENERATION_INCREASED →Transitioned To · PAHC INVENTORY_PRESSURE_DECREASED →Transitioned To · PAHC MARGIN_INCREASED →Transitioned To · PAHC PROFITABILITY_INCREASED →Transitioned To · PAHC SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.